BRK-B vs GLRE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
GLRE presents a classic value trap profile: fundamentally undervalued but plagued by poor earnings quality and bearish internal sentiment. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the stock trades at a significant discount to its Graham Number ($32.3) and below book value (P/B 0.90). Despite strong top-line revenue growth of 39.7%, the catastrophic YoY EPS decline of -134.3% and consistent earnings misses suggest operational instability. The valuation is attractive, but the combination of bearish insider selling and poor earnings track record offsets the value proposition.
Compare Another Pair
Related Comparisons
BRK-B vs GLRE: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Greenlight Capital Re, Ltd. (GLRE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.